疾病
白血病Leukaemia
白血病 · ICD-10：C91–C95 — Leukaemia
关键数据
仅为已发布的数值。每个图块都会打开带有其来源、年份与口径的章节。
疾病详情
- 规范中文名
- 白血病
- 英文名
- Leukaemia
以中文写出的数值按来源原样引用。
又称
- 白血病
- Leukaemia
治疗费用区间
以下每个区间都按一种计费口径发布：医保报销前。 来源未发布报销后数值，因此这里不展示。
| 治疗路径 | 费用区间 | 价格依据 | 数据年份 |
|---|---|---|---|
| 化疗 | 20000 – 20000 CNY | 病种打包全包价 | 2020 |
| 化疗 | 54000 – 54000 CNY | 病种打包全包价 | 2020 |
| 化疗 | 95000 – 95000 CNY | 病种打包全包价 | 2020 |
| 化疗 | 87000 – 87000 CNY | 病种打包全包价 | 2020 |
| 化疗 | 100000 – 100000 CNY | 病种打包全包价 | 2020 |
| 化疗 | 7000 – 7000 CNY | 病种打包全包价 | 2020 |
| 化疗 | 9000 – 9000 CNY | 病种打包全包价 | 2020 |
| 化疗 | 36000 – 36000 CNY | 病种打包全包价 | 2020 |
| 化疗 | 10500 – 10500 CNY | 病种打包全包价 | 2020 |
| 化疗 | 42200 – 42200 CNY | 病种打包全包价 | 2020 |
| 化疗 | 52700 – 52700 CNY | 病种打包全包价 | 2020 |
| 化疗 | 95000 – 95000 CNY | 病种打包全包价 | 2020 |
| 化疗 | 70800 – 70800 CNY | 病种打包全包价 | 2020 |
| 化疗 | 28000 – 28000 CNY | 病种打包全包价 | 2020 |
| 化疗 | 11500 – 11500 CNY | 病种打包全包价 | 2020 |
| 化疗 | 66300 – 66300 CNY | 病种打包全包价 | 2020 |
| 化疗 | 20800 – 20800 CNY | 病种打包全包价 | 2020 |
| 化疗 | 36500 – 36500 CNY | 病种打包全包价 | 2020 |
| 化疗 | 30100 – 30100 CNY | 病种打包全包价 | 2020 |
| 化疗 | 50000 – 50000 CNY | 病种打包全包价 | 2020 |
| 化疗 | 72000 – 72000 CNY | 病种打包全包价 | 2020 |
| 化疗 | 30800 – 30800 CNY | 病种打包全包价 | 2020 |
| 化疗 | 43300 – 43300 CNY | 病种打包全包价 | 2020 |
| 化疗 | 72000 – 72000 CNY | 病种打包全包价 | 2020 |
| 化疗 | 95400 – 95400 CNY | 病种打包全包价 | 2020 |
上方的条形共用同一刻度：每条从该行已发布的下限值起，到其上限值止。本页最高的上限值为 100000 CNY。每行保留自己的数据年份与口径。
该疾病的 25 个费用区间，来源见各行页面。
以中文写出的数值按来源原样引用。
五年生存
5 年生存率 30.6% 95% 置信区间 30.2–31.1
- 人群
- 总体（全分期合并）· 年龄标准化相对生存率
- 时期
- 2019–2021
- 发布机构
- 国家癌症中心
- 数值性质
- 估计值（混合法）
- 登记范围
- 281 个肿瘤登记处
- 分期数据可用性
- 未发布
以中文写出的数值按来源原样引用。
如何解读该数据。 它按全分期合并发布，因此是全国登记数据中所有人的平均值，而不是对某个人的预后。对多数癌症而言，确诊时的分期是生存差异背后最强的单一因素：通常，癌症发现得越早，生存率越高；发现得越晚，越低。不同癌症之间的比较也受到各自通常确诊早晚的影响，因此一个较低的数值本身并不意味着诊疗更差。
该数值是相对生存率：它把被诊断患此癌的人与一般人群中同年龄、同性别的人相比较，且为年龄标准化，因此它不是五年后仍存活患者所占的比例。它以估计值（混合分析）发布，因为登记报告存在滞后，故国家癌症中心对最近一段时期作了模型估计。作为参照，同一来源发布 2019–2021 年全部癌症合计的五年相对生存率为 43.7%。
在该疾病上有已发布记录的医院
依据官方公开数据来源筛选
这些医院依据官方公开数据来源筛选——复旦大学医院专科声誉排行榜、国家临床重点专科名单与国家临床医学研究中心——因此卡片上的每一行都可与其已发布的来源核对。这不是付费或推广位。
这些医院是如何筛选的
入选。当某疾病所归属的专科满足以下至少一项时，医院即被列入该疾病：在复旦大学医院专科声誉排行榜中有一个名次或提名；有一条 A、B 或 C 级的国家临床重点专科记录；或该专科有一个国家临床医学研究中心或国家重点实验室。JCI 认证仅作徽标展示；它绝不决定入选，也绝不决定排序。
排序。第 1 步：该专科在复旦榜中的第 1 至第 10 名。第 2 步：又一个复旦名次，或一个提名。第 3 步：一条 A 级国家临床重点专科。第 4 步：一条 B 级国家临床重点专科。第 5 步：该专科的一个国家临床医学研究中心或国家重点实验室，研究中心优先于实验室。第 6 步：一条 C 级国家临床重点专科——这是我们发布的一条没有独立官方来源的记录，因此排在其余之后。
平局。在同一步骤内：复旦名次更好的在前，其次重点专科等级更高者（A 先于 B，B 先于 C），再次省份，再次城市，最后医院名称——与医院目录所用的省—市—名称顺序相同。最多列出八家医院。
当名单较短时。五家及以上：列出前八家。三家或四家：全部列出，并有一个可展开的折叠区，把其余记录补至最多八条，每条都带其证据等级。一两家：同上，且该折叠区默认展开，并有一行说明有多少家医院有可靠的公开记录。没有：页面说明未找到可靠的公开记录，并链接到专科目录。绝不为了凑数而编造名次、机构或数量。
复旦排行榜是中国临床医生最广泛认可的医院专科声誉排行榜，由复旦大学医院管理研究所每年发布。
-
四川大学华西医院West China Hospital, Sichuan University
国家临床重点专科
- Hematology（A 级） https://wcums.scu.edu.cn/kxyan_jiu/gjlczdzk.htm
同时上榜：在复旦榜中为 General Surgery #3, Thoracic Surgery #4, Urology #2 （并列）。
-
山东大学齐鲁医院Qilu Hospital of Shandong University
国家临床重点专科
同时上榜：在复旦榜中为 Gynecology #7 （并列）, Otorhinolaryngology 获提名, Gastroenterology 获提名。
-
浙江大学医学院附属第一医院The First Affiliated Hospital, Zhejiang University School of Medicine
国家临床重点专科
- Hematology（A 级） http://zdygb.zju.edu.cn/2014/0106/c34026a1762975/page.htm
同时上榜：在复旦榜中为 General Surgery #7, Urology #9, 传染感染 #2。
-
上海交通大学医学院附属瑞金医院Ruijin Hospital
国家临床重点专科
- Hematology（B 级） https://www.rjh.com.cn/2018RJPortal/lcyxy2019/sy/jj/index.shtml
同时上榜：在复旦榜中为 General Surgery #4, Thoracic Surgery #7 （并列）, Respiratory Medicine #5。
-
北京医院Beijing Hospital
国家临床重点专科
同时上榜：在复旦榜中为 Urology 获提名。
-
北京大学人民医院Peking University People's Hospital
国家临床重点专科
- Hematology（B 级） https://www.pkuph.cn/news_details/26715.html
同时上榜：在复旦榜中为 General Surgery #10, Thoracic Surgery #7, Gynecology #7。
-
北京大学第三医院Peking University Third Hospital
国家临床重点专科
- Hematology（B 级） https://www.puh3.net.cn/yygk/zdxk.htm
同时上榜：在复旦榜中为 Gynecology #4, Urology 获提名, Gastroenterology 获提名。
-
中国科学技术大学附属第一医院（安徽省立医院）Anhui Provincial Hospital
国家临床重点专科
- Hematology（B 级） https://www.ahslyy.com.cn/nanqu/col456/892156
同时上榜：在复旦榜中为 General Surgery 获提名, Otorhinolaryngology 获提名。
临床试验（在研治疗）
除标准治疗外，针对 Leukaemia 的临床研究目前可能在中国开放招募受试者。在研治疗尚未获监管机构批准为标准疗法——它们是临床研究，而非常规治疗。每条记录都注明主要研究者与开展研究的医院。如有兴趣，请联系医院了解是否符合条件，并自行决定是否申请。
-
研究 The Efficacy and Safety of BCL-2 Inhibitors Combined with the HyperCVAD Regimen in the Treatment of Newly Diagnosed T-lymphoblastic Leukemia/ Lymphoma
- 主要研究者
- Xianmin Song, MD · Investigator Official Title
- 医院
- Shanghai General Hospital
- 状态
- 招募中
- 登记库
- NCT06598722
-
研究 To Observe and Evaluate the Efficacy and Safety of Inaticabtagene Autoleucel Injection in the Treatment of Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia in Adults in the Real World
- 医院
- Peking University People's Hospital
- 状态
- 招募中
- 登记库
- NCT06450067
-
研究 A Clinical Study Evaluating the Safety and Efficacy of IL-15-armored Novel CAR-T Cell Therapy in Patients With Relapsed/Refractory Multiple Myeloma and Plasma Cell Leukemia
- 主要研究者
- FengYan Jin · Clinical Professor of Hematology Department
- 医院
- The First Hospital of Jilin University
- 状态
- 招募中
- 登记库
- NCT07509086
-
研究 Avapritinib Combined With Standard Therapy for the Treatment of Newly Diagnosed KIT Mutation Acute Myeloid Leukemia With t(8;21)(q22;q22.1); Inv(16)(p13.1q22) or t(16;16)(p13.1;q22): a Prospective, Multi-center, Single-arm, Two-cohorts Study
- 主要研究者
- Chen Suning · Prof.
- 医院
- First Affiliated Hospital of Guangzhou Medical University
- 状态
- 招募中
- 登记库
- NCT07028073
-
研究 An Open-Label, Multi-Center, Phase Ib/II Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Anti-tumor Activity of YK012 in Participants With B-cell Acute Lymphoblastic Leukemia
- 医院
- Sun Yat-sen Memorial Hospital, Sun Yat-sen University
- 状态
- 招募中
- 登记库
- NCT06580301
另有 145 项已登记研究
-
研究 A Phase IB Open-Label, Multicenter Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Mosunetuzumab and a Combined Regimen of Mosunetuzumab and Venetoclax in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia
- 医院
- Peking University People's Hospital
- 状态
- 招募中
- 登记库
- NCT05091424
-
研究 Using Multiparametric Flow Cytometry to Detect Peripheral Blood and Bone Marrow Leukaemia Stem Cells for Relapse Prediction in Pediatric Acute Myeloid Leukaemia: a Prospective Study
- 主要研究者
- Chang Yingjun · Chief Physician
- 医院
- Peking University People's Hospital
- 状态
- 招募中
- 登记库
- NCT06452732
-
研究 Venetoclax-Azacitidine in Combination With Chidamide and CAG Versus 3+7 Regimen in Fit Older Patients With Acute Myeloid Leukaemia：A Multicenter, Randomized, Controlled, Phase 3 Trial
- 主要研究者
- Daihong Liu · Department of Hematology, The Fifth Medical Center of Chinese PLA General Hospital
- 医院
- Chinese PLA General Hospital
- 状态
- 招募中
- 登记库
- NCT07514936
-
研究 A Multicenter, Prospective, Randomized Controlled Clinical Study Comparing the Efficacy of VHAG and Traditional Chemotherapy Regimens in the Treatment of Adult Newly Diagnosed Early Precursor T-cell Acute Lymphoblastic Leukemia (ETP-ALL)
- 医院
- First Affiliated Hospital of Guangzhou Medical University
- 状态
- 招募中
- 登记库
- NCT06361329
-
研究 An Open-label, Clinical Study of CD7-targeted CAR-T Cells for the Treatment of Measurable Residual Disease of T-lymphoblastic Leukaemia/Lymphoma Post Allogeneic Stem Cell Transplantation
- 主要研究者
- Xiao-Jun Huang · Chief
- 医院
- Peking University People's Hospital
- 状态
- 招募中
- 登记库
- NCT07280494
-
研究 A Multicenter Prospective Clinical Study of Inotuzumab Ozogamicin (INO) in the Treatment of Minimal Residual Disease Recurrent After Hematopoietic Stem Cell Transplantation of Acute Lymphoblastic Leukemia (ALL)
- 主要研究者
- Sheng-Li Xue, MD · Professor
- 医院
- First Affiliated Hospital of Guangzhou Medical University
- 状态
- 招募中
- 登记库
- NCT05940961
-
研究 A Phase I/IIa, Open-Label Dose Escalation and Dose Expansion Study of Intravenous GFH009 Single Agent and in Combination With Venetoclax and Azacitidine in Patients With Relapsed/Refractory Hematologic Malignancies and High-Risk Newly Diagnosed AML
- 医院
- First Affiliated Hospital of Guangzhou Medical University
- 状态
- 招募中
- 登记库
- NCT04588922
-
研究 MRD-positive AML: a Prospective, Single-arm, Multicenter Platform Clinical Study
- 医院
- Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College
- 状态
- 招募中
- 登记库
- NCT07131059
-
研究 A Clinical Study on the Safety and Effectiveness of Targeting CD5 CAR-T Cells in the Treatment of r/r CD5+ T-lymphoma
- 主要研究者
- He Huang · Clinical Professor
- 医院
- First Affiliated Hospital of Guangzhou Medical University
- 状态
- 招募中
- 登记库
- NCT06633341
-
研究 Low-intensity Chemotherapy Combined With Targeted-Immunotherapy for Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: A Prospective Clinical Cohort Study
- 医院
- Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College
- 状态
- 招募中
- 登记库
- NCT07493161
-
研究 Clinical Study of CD5 Targeting Chimeric Antigen Receptor NK Cells (CAR-NK) in the Treatment of Relapse/Refractory T-Cell Hematologic Malignancies
- 医院
- Tongji Hospital, Tongji Medical College, Huazhong University of Science & Technology
- 状态
- 招募中
- 登记库
- NCT06909474
-
研究 Open-label, Dose-escalation Phase 1 Clinical Study of SENL101 Autologous T Cell Injection in the Treatment of Adult Patients With Relapsed or Refractory T-LBL/ALL
- 医院
- Ruijin Hospital
- 状态
- 招募中
- 登记库
- NCT06136364
-
研究 A Multicenter, Single-Arm Clinical Study of the Venetoclax, Ivosidenib, and Azacitidine Triple-Drug Regimen in the Treatment of Chemotherapy-eligible Adult Patients With IDH1-Mutated Acute Myeloid Leukemia.
- 医院
- Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College
- 状态
- 招募中
- 登记库
- NCT06611839
-
研究 The Safety and Efficacy for Anti-human CLL-1 CAR-NK Cells in Subjects With Relapsed/Refractory Acute Myeloid Leukemia
- 主要研究者
- Xianmin Song, MD · Doctor
- 医院
- Shanghai General Hospital
- 状态
- 招募中
- 登记库
- NCT06307054
-
研究 A Study of Chidamide With AZA in MRD Positive AML After Transplant
- 主要研究者
- WENG Jian yu · professor
- 医院
- Guangdong Provincial People's Hospital
- 状态
- 招募中
- 登记库
- NCT06066905
-
研究 A Global Multicenter Open Label Randomized Phase III Confirmatory Study of Lisaftoclax (APG-2575) in Combination With Acalabrutinib vs Immunochemotherapy in Patients With Newly Diagnosed Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma.
- 医院
- First Affiliated Hospital of Guangzhou Medical University
- 状态
- 招募中
- 登记库
- NCT06319456
-
研究 Leukemia Stem Cell-based Assay to Predict Relapse and Survival in Patients With Acute Myeloid Leukemia
- 主要研究者
- Siqi Li · Chief Technician
- 医院
- Peking University People's Hospital
- 状态
- 招募中
- 登记库
- NCT07537738
-
研究 A Single-arm, Open-label Clinical Study to Evaluate the Safety, Tolerability, and Efficacy of U32 Injection in Patients With Acute Myeloid Leukemia.
- 医院
- First Affiliated Hospital of Guangzhou Medical University
- 状态
- 招募中
- 登记库
- NCT07036250
-
研究 Bridging Allogeneic Hematopoietic Stem Cell Transplantation or Not After CD19 CAR - T (S1904) Cell Therapy for r/r B-cell Acute Lymphoblastic Leukemia, a Prospective, Open, Multicenter, Randomized, Control Study (COMPLETE Study)
- 主要研究者
- Xiao-Jun Huang · Prof.
- 医院
- Peking University People's Hospital
- 状态
- 招募中
- 登记库
- NCT06581081
-
研究 Clinical Study on the Safety and Efficacy of Autologous Hematopoietic Stem Cell Transplantation Combined With BCMA-CAR-T in the Treatment of Ultra-high Risk Multiple Myeloma
- 医院
- Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College
- 状态
- 招募中
- 登记库
- NCT07109323
-
研究 Clinical Study Protocol to Evaluate the Safety and Efficacy of γδ T Cells for the Prevention of Relapse After Allogeneic Transplantation in Patients With High-risk Acute Myeloid Leukemia
- 主要研究者
- Donghua Zhang · Director
- 医院
- Tongji Hospital, Tongji Medical College, Huazhong University of Science & Technology
- 状态
- 招募中
- 登记库
- NCT07237230
-
研究 A Clinical Study Exploring the Safety, Efficacy and Cell Metabolic Kinetics of Universal Car-t Cell Injection in CD19 and / or CD20 Positive Relapsed / Refractory B-cell Acute Lymphoblastic Leukemia in Adolescents, Children and Adults
- 主要研究者
- MEI HENG · Professor
- 医院
- Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
- 状态
- 招募中
- 登记库
- NCT07470073
-
研究 Reduced Intensity Allogeneic Hematopoietic Stem Cell Transplantation in Comparison to Consolidation Therapy Based Venetoclax for Elderly Patients With Acute Myeloid Leukemia After First CR
- 主要研究者
- He Huang · Discipline Leader of Bone Marrow Transplant Center
- 医院
- The First Affiliated Hospital, Zhejiang University School of Medicine
- 状态
- 招募中
- 登记库
- NCT06571825
-
研究 Study of the Efficacy and Safety of Venetoclax as Consolidation to Achieve Fix-Duration Treatment in CLL Patients Treated With BTK Inhibitor Monotherapy
- 医院
- Jiangsu Province Hospital
- 状态
- 招募中
- 登记库
- NCT06958705
-
研究 A Perspective, Multicenter, Open-label and Observational Trial for Unrelated Umbilical Cord Blood Stem Cell Microtransplantation Combined With Azacitidine Based Treatment for Advanced MDS,CMML-2 and Secondary AML.
- 医院
- Jiangsu Province Hospital
- 状态
- 招募中
- 登记库
- NCT05584761
-
研究 The Efficacy and Safety of Homoharringtonine Combined With Venetoclax and Azacitidine Versus Standard Chemotherapy or VA in the Treatment of Acute Myeloid Leukemia With High-risk, a Multicenter, Prospective, Randomized Study
- 医院
- Nanfang Hospital
- 状态
- 招募中
- 登记库
- NCT06810791
-
研究 The Safety and Efficacy of CD19 & CD22 Bispecific CAR T Cells in Treating Relapsed / Refractory B Cell Hematological Tumors
- 主要研究者
- MEI HENG · Proferssor, Cheif Doctor
- 医院
- Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
- 状态
- 招募中
- 登记库
- NCT06735495
-
研究 Haploidentical Hematopoietic Cell Transplantation Combined With an Unrelated Cord Blood Unit for Acute T Cell Lymphoblastic Leukemia Compared to Haploidentical Hematopoietic Cell Transplantation: a Multicenter, Randomized, Open-label Trial
- 医院
- First Affiliated Hospital of Guangzhou Medical University
- 状态
- 招募中
- 登记库
- NCT06381817
-
研究 A Prospective Cohort Study of a Pediatric-Inspired Chemotherapy Regimen Combined With Venetoclax and Immunotherapy for the Treatment of Adult Ph-Negative Acute Lymphoblastic Leukemia
- 医院
- Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College
- 状态
- 招募中
- 登记库
- NCT07495631
-
研究 A Phase 1/2, Open-Label, Dose-Escalation and Expansion Study of the Bruton Tyrosine Kinase-Targeted Protein-Degrader BGB-16673 in Chinese Patients With B-Cell Malignancies
- 医院
- First Affiliated Hospital of Guangzhou Medical University
- 状态
- 招募中
- 登记库
- NCT05294731
-
研究 A Randomized, Controlled, Prospective Study on the Efficacy and Safety of Active Immunity Induced by Autologous Peptides for Maintenance Therapy in Acute Myeloid Leukemia (AML)
- 主要研究者
- HuangMeiJuan · Clinical Professor
- 医院
- Fujian Medical University Union Hospital
- 状态
- 招募中
- 登记库
- NCT07551037
-
研究 Assessment of the Safety and Efficacy of Allogeneic CD19-targeted CAR-γδT Cell Infusion Therapy in Relapsed/Refractory B Cell Acute Lymphoblastic Leukemia: A Single-Arm, Open-Label, Prospective Study
- 医院
- First Affiliated Hospital of Guangzhou Medical University
- 状态
- 招募中
- 登记库
- NCT06696833
-
研究 A Multicenter, Open-label, Prospective, Randomized Controlled Study to Optimize the Treatment of Patients With Acute Myeloid Leukemia Based on Early Peripheral Blood Minimal Residual Disease
- 主要研究者
- Yehui Tan · Professor
- 医院
- The First Hospital of Jilin University
- 状态
- 招募中
- 登记库
- NCT07023588
-
研究 Reduced-dose Anti-thymocyte Globulin Plus Mini-dose Post-transplant Cyclophosphamide for GVHD Prevention in Haploidentical Donor HCT for Hematologic Malignancy
- 主要研究者
- Xiao-Jun Huang · Peking University People's Hospital
- 医院
- Peking University People's Hospital
- 状态
- 招募中
- 登记库
- NCT06984536
-
研究 Exposure-Response and Prognostic Analysis of Venetoclax Therapeutic Drug Monitoring in Newly Diagnosed AML
- 主要研究者
- CHEN Jia · Chief Physician of Hematology. Clinical Professor. Principal Investigator
- 医院
- First Affiliated Hospital of Guangzhou Medical University
- 状态
- 招募中
- 登记库
- NCT07670130
-
研究 Clinical Study to Evaluate the Safety and Efficacy of Daratumumab and Carfilzomib-based Induction/Consolidation/Maintenance Therapy in Transplant-eligible, Ultra High-risk, Newly Diagnosed Multiple Myeloma
- 主要研究者
- Chunyan Sun · Professor
- 医院
- Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
- 状态
- 招募中
- 登记库
- NCT06140966
-
研究 A Phase 3, Open-Label, Randomized, Multicenter Study to Evaluate Anti-tumor Efficacy of DZD8586 Versus Investigator's Choice in Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
- 医院
- Jiangsu Province Hospital
- 状态
- 招募中
- 登记库
- NCT07139873
-
研究 Haploidentical Combined With Cord Blood Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia and Myelodysplastic Syndromes: A Prospective, Multicenter Clinical Study
- 医院
- Fujian Medical University Union Hospital
- 状态
- 招募中
- 登记库
- NCT07588360
-
研究 The Efficacy of Thalidomide for the Symptomatic Large Granular Lymphocytic Leukemia - a Prospective Phase Ⅱ Multicenter Clinical Trial From China
- 医院
- Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College
- 状态
- 招募中
- 登记库
- NCT06530576
-
研究 A Phase I Study to Evaluate the Safety, Pharmacokinetics, and Preliminary Efficacy of APG-3288 in Patients With Relapsed/Refractory Hematological Malignancies
- 医院
- Henan Cancer Hospital
- 状态
- 招募中
- 登记库
- NCT07424833
-
研究 An Open-Label, Single-Arm, Phase II Exploratory Study of ABL and JAK Kinase Inhibitors With Chemotherapy and Venetoclax in Adult Patients With Ph-like ALL
- 医院
- Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College
- 状态
- 招募中
- 登记库
- NCT07454226
-
研究 Cord Blood-derived CD70-targeting CAR-NK Cell Therapy for Refractory/Relapsed T Cell Lymphoma and Acute Myeloid Leukemia
- 医院
- The Second Affiliated Hospital Zhejiang University School of Medicine
- 状态
- 招募中
- 登记库
- NCT06696846
-
研究 HEC73543 Versus Salvage Chemotherapy in Relapsed or Refractory FLT3-ITD Acute Myeloid Leukemia: a Multicenter, Open-label, Randomized Phase 3 Trial
- 医院
- First Affiliated Hospital of Guangzhou Medical University
- 状态
- 招募中
- 登记库
- NCT05586074
-
研究 The Impact of Artificial Intelligence-Assisted Health Education on Patients' Intention to Participate in Clinical Trials: A Cluster-Randomised Controlled Trial
- 主要研究者
- Fuling Zhou · Dean, School of Nursing, Wuhan University; Tenured Full Professor, Director of Department of Hematology, zhongnan Hospital,Wuhan University
- 医院
- Zhongnan Hospital of Wuhan University
- 状态
- 招募中
- 登记库
- NCT07305337
-
研究 The Efficacy of Allogeneic Hematopoietic Stem Cell Transplantation in Newly Diagnosed High-relapse-risk CEBPA Mutant Acute Myeloid Leukemia
- 主要研究者
- Shen yang · Chief physician
- 医院
- Ruijin Hospital
- 状态
- 招募中
- 登记库
- NCT06458257
-
研究 A Multicenter, Open, Dose Escalation and Dose Expansion Phase I Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of STI-8591 in Subjects With Advanced Acute Myeloid Leukemia (AML)
- 医院
- First Affiliated Hospital of Guangzhou Medical University
- 状态
- 招募中
- 登记库
- NCT05947344
-
研究 A Phase 2 Study of MAX-40279 Combined With Venetoclax and Azacitidine in Unfit Newly Diagnosed Acute Myeloid Leukemia
- 医院
- Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College
- 状态
- 招募中
- 登记库
- NCT07743112
-
研究 CD180 CART Cell Injection in the Treatment of Relapsed or Refractory CD180 Positive Hematologic Malignancies: a Prospective, Single-arm, Single-center Clinical Study.
- 医院
- Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College
- 状态
- 招募中
- 登记库
- NCT07106749
-
研究 Phase I Clinical Trial Protocol for Tolerability and Pharmacokinetics of TQB3455 Tablets in Patients With Hematological Malignancies
- 医院
- Peking University People's Hospital
- 状态
- 招募中
- 登记库
- NCT06550713
-
研究 To Evaluate Safety and Efficiency of AZA Combined With Chidamide as Maintenance Therapy in High-risk Acute Myeloid Leukemia Patients After Allogeneic Hematopoietic Stem Cell Transplantation：A Multicenter, Single-arm Study
- 医院
- Nanfang Hospital
- 状态
- 招募中
- 登记库
- NCT05270200
-
研究 A Prospective,Randomized,and Comparative Study on the Efficacy of Venetoclax Combined With CACAG Regimen and BAT Regimen in the Treatment of Relapsed/Refractory Acute Myeloid Leukemia
- 主要研究者
- Daihong Liu · doctor
- 医院
- Chinese PLA General Hospital
- 状态
- 招募中
- 登记库
- NCT06084819
-
研究 A Phase 2, Multicenter, Single-arm, Open-label Study on the Efficacy and Safety of PI3K Inhibitors in Relapsed/Refractory Large Granular T Lymphocytic Leukemia
- 医院
- Anhui Provincial Hospital
- 状态
- 招募中
- 登记库
- NCT06224257
-
研究 A Phase I Clinical Study on the Safety, Tolerability, and Efficacy of KSV01 Injection in Patients With Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia
- 主要研究者
- He Huang · Clinical Professor
- 医院
- The First Affiliated Hospital, Zhejiang University School of Medicine
- 状态
- 招募中
- 登记库
- NCT07246707
-
研究 An Open-label, Multi-center, Phase I Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of IBR733 Cell Injection in Acute Myeloid Leukemia
- 医院
- First Affiliated Hospital of Guangzhou Medical University
- 状态
- 招募中
- 登记库
- NCT06234904
-
研究 An Exploratory Study on Targeted CD22/CD19 Chimeric Antigen Receptor (CAR)-T Cell Immunotherapy for Enhanced Consolidation Therapy of Standard-risk B-cell Acute Lymphoblastic Leukemia
- 主要研究者
- Liping Dou · Director
- 医院
- Chinese PLA General Hospital
- 状态
- 招募中
- 登记库
- NCT07575919
-
研究 Multicenter, Randomized Controlled Clinical Study on Early Application of Realgar-Indigo Naturalis Formula (RIF) for Treatment of Acute Promyelocytic Leukemia (APL)
- 医院
- The First Affiliated Hospital of Xi'an Jiaotong University
- 状态
- 招募中
- 登记库
- NCT07503730
-
研究 Effectiveness and Safety of Blinatumomab and Donor Lymphocyte Infusion in Maintenance Therapy After Allogeneic Hematopoietic Stem Cell Transplantation for High-risk Ph Negative B Cell Acute Lymphoblastic Leukemia：Phrase II, Exploratory Study
- 医院
- The First Affiliated Hospital, Zhejiang University School of Medicine
- 状态
- 招募中
- 登记库
- NCT07105579
-
研究 Clinical Trial for the Safety and Efficacy of CAR-T Cells Therapy for Patients With the Central Nervous System Involvement of Relapsed and/or Refractory B-cell Acute Lymphoblastic Leukemia or B-cell Non-Hodgkin's Lymphoma
- 主要研究者
- He Huang · Clinical Professor
- 医院
- First Affiliated Hospital of Guangzhou Medical University
- 状态
- 招募中
- 登记库
- NCT04532203
-
研究 PA3-17 Injection for the Treatment of Subjects With Relapsed/Refractory T-Lymphoblastic Leukemia/Lymphoma: A Single-Arm, Open-Label Phase II Clinical Trial
- 医院
- First Affiliated Hospital of Guangzhou Medical University
- 状态
- 招募中
- 登记库
- NCT07188610
-
研究 A Phase I Dose-Escalation and Phase II Study of Nanobody-Based CD19/CD22 Tandem Dual Chimeric Antigen Receptor (CAR) T-cell Therapy in Patients With Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia
- 主要研究者
- Xiao-Jun Huang · Director of Peking University Institute of Hematology
- 医院
- Peking University People's Hospital
- 状态
- 招募中
- 登记库
- NCT06880913
-
研究 Safety and Efficacy of Mitoxantrone Hydrochloride Liposome Based DCMG Regimen for Relapsed/refractory Acute Myeloid Leukemia
- 主要研究者
- Xiao-Ning Gao · Chief Physician
- 医院
- Chinese PLA General Hospital
- 状态
- 招募中
- 登记库
- NCT06741722
-
研究 A Phase 1, Open-label, Multicentre Study Evaluating the Safety, Tolerability, Pharmacokinetic/Pharmacodynamic Characteristics, and Preliminary Efficacy of CG009301 for Injection in Adult Subjects With Relapsed or Refractory Haematological Malignancies
- 医院
- The First Affiliated Hospital of Nanchang University
- 状态
- 招募中
- 登记库
- NCT07347171
-
研究 A Phase I/II Single-center Study Evaluating the Safety and Efficacy of BCOR and ZC3H12 Genes Knock-out CD19-targeting CAR-T Cell Therapy in Adults With Refractory/Relapsed B-cell Acute Lymphoblastic Leukaemia
- 主要研究者
- Han weidong · Director of Biotherapeutic Department
- 医院
- First Hospital of China Medical University
- 状态
- 招募中
- 登记库
- NCT07008885
-
研究 A Prospective, Multicenter Clinical Study on The Safety and Efficacy of Avapritinib in The Treatment of Relapsed/Refractory Pediatric Core Binding Factor Acute Myeloid Leukemia (CBF-AML) With KIT Mutation
- 主要研究者
- Shaoyan Hu · Study Chair
- 医院
- Anhui Provincial Hospital
- 状态
- 招募中
- 登记库
- NCT06316960
-
研究 The Efficacy and Safety of Third Generation Tyrosine Kinase Inhibitors Combined With Azacitidine and B-cell Lymphoma-2 Inhibitor in Patients With Myeloid Blast Phase Chronic Myeloid Leukemia
- 主要研究者
- Qian Jiang · Professor
- 医院
- Peking University People's Hospital
- 状态
- 招募中
- 登记库
- NCT06390306
-
研究 The Safety and Efficay Investigation of IL-5 CAR-T Cell Therapy for Patients With Refractory/Relapsed Eosinophilic Leukemia
- 主要研究者
- He Huang · Clinical Professor
- 医院
- First Affiliated Hospital of Guangzhou Medical University
- 状态
- 招募中
- 登记库
- NCT07257640
-
研究 The Efficacy and Safety of VA Alternating With Low-dose CHA in the Treatment of Newly Diagnosed Unfit AML: a Prospective, Multi-centers, Single Arm Phase II Study
- 主要研究者
- Jie Sun · Principle Attending, Associated Professor
- 医院
- Beijing Chao-Yang Hospital, Capital Medical University
- 状态
- 招募中
- 登记库
- NCT07172204
-
研究 An Exploratory Clinical Study of CAR-T Cell Immunotherapy Using Polymer-lipid Particles to Deliver CAR1920 mRNA Targeting CD19/CD20 for Thetreatment of Relapsed/Refractory B-cell Lymphoma/Leukemia
- 主要研究者
- Daihong Liu · Dr.
- 医院
- Chinese PLA General Hospital
- 状态
- 招募中
- 登记库
- NCT07321301
-
研究 Blinatumomab Sequential Donor Lymphocyte Infusion in Acute B Lymphocytic Leukemia Observation of Therapeutic Effect in Patients With Recurrence After Allogeneic Hematopoietic Stem Cell Transplantation
- 主要研究者
- Suping ZHANG · visiting staff
- 医院
- First Affiliated Hospital of Zhengzhou University
- 状态
- 招募中
- 登记库
- NCT06339775
-
研究 A Preliminary Study to Evaluate the Safety, Tolerability, Preliminary Efficacy and Pharmacokinetic Profile of KQ-2002 (CD19/CD22 CAR-T) in Adults With Recurrent or Refractory Acute Lymphoblastic Leukemia or Non-Hodgkin's Lymphoma
- 主要研究者
- Rong Tao · Chief physician
- 医院
- The First Affiliated Hospital of Nanchang University
- 状态
- 招募中
- 登记库
- NCT06445803
-
研究 Clinical Study of LV009 Injection for the Treatment of Relapsed/Refractory CD19-Positive Hematologic and Lymphoid Malignancies
- 医院
- First Affiliated Hospital of Guangzhou Medical University
- 状态
- 招募中
- 登记库
- NCT07284927
-
研究 A Phase Ib/II, Open-Label, Dose-Escalation and Cohort Expansion Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of PBSS1113 in Combination With Azacitidine in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome
- 医院
- The First Affiliated Hospital, Zhejiang University School of Medicine
- 状态
- 招募中
- 登记库
- NCT07761533
-
研究 A Phase 1 Study of ICP-248 in Combination With Azacitidine for the Treatment in Patients With Myeloid Malignancies.
- 医院
- Anhui Provincial Hospital
- 状态
- 招募中
- 登记库
- NCT06656494
-
研究 Dose Escalation Study of Liposomal Mitoxantrone Hydrochloride Injection Combined With Decitabine and Cytarabine (D-CMG) for the Treatment of Elderly Newly Diagnosed Acute Myeloid Leukemia (AML) Patients
- 主要研究者
- Bing, Xu · Principal Investigator
- 医院
- First Affiliated Hospital of Guangzhou Medical University
- 状态
- 招募中
- 登记库
- NCT06651866
-
研究 The First Affiliated Hospital, Zhejiang University School of Medicine
- 主要研究者
- He Huang · The President of the First Affiliated Hospital, Zhejiang University School of Medicine
- 医院
- First Affiliated Hospital of Guangzhou Medical University
- 状态
- 招募中
- 登记库
- NCT06076226
-
研究 The Efficacy of Allogeneic Hematopoietic Stem Cell Transplantation in Newly Diagnosed High-relapse-risk Core-binding-factor Acute Myeloid Leukemia
- 主要研究者
- Shen yang · Chief physician
- 医院
- Ruijin Hospital
- 状态
- 招募中
- 登记库
- NCT06458244
-
研究 A Multicenter, Single-Arm, Prospective Clinical Study of Thiotepa Combined With Busulfan and Fludarabine Conditioning Regimen for Haploidentical Hematopoietic Stem Cell Transplantation in Elderly Patients With High-Risk Acute Myeloid Leukemia
- 主要研究者
- Xiao-Jun Huang · Prof.
- 医院
- Peking University People's Hospital
- 状态
- 招募中
- 登记库
- NCT06869265
-
研究 An Early Exploratory Clinical Study of the Safety, Tolerability and Preliminary Efficacy of JY231 Injection in the Treatment of Relapsed or Refractory B-cell Lymphoma/Leukaemia
- 主要研究者
- Jia Wei · professor
- 医院
- Tongji Hospital, Tongji Medical College, Huazhong University of Science & Technology
- 状态
- 招募中
- 登记库
- NCT06689917
-
研究 An Exploratory Study on the Safety and Efficacy of Luspatercept in the Treatment of Anemia Following Allogeneic Hematopoietic Stem Cell Transplantation for Acute Leukemia
- 主要研究者
- Liang Zhao · Professor
- 医院
- Zhujiang Hospital of Southern Medical University
- 状态
- 招募中
- 登记库
- NCT07362095
-
研究 A Single-arm, Prospective Study of a Cladribine-Bridged Lisaftolax and Busulfan Conditioning Regimen in Allogeneic Hematopoietic Stem Cell Transplantation for Relapsed/Refractory Myelodysplastic Syndromes and Acute Myeloid Leukemia in Elderly Patients
- 医院
- First Affiliated Hospital of Guangzhou Medical University
- 状态
- 招募中
- 登记库
- NCT07500753
-
研究 A Prospective, Multicenter, and Exploratory Study of Mitoxantrone Liposomes, Cytarabine and G-CSF Combined With Vineclavone in the Treatment ofRecurrent Adult AML and MDS-EB-2/Elder AML
- 医院
- Ruijin Hospital
- 状态
- 招募中
- 登记库
- NCT06329999
-
研究 Prospective Randomized Study of the Effectiveness and Safety of Chemotherapy Protocols Containing Daunorubicin /Idarubicin ± Silibinin in Treating Newly Diagnosed AML (Non-M3)
- 主要研究者
- HuangMeiJuan · Chief Physician
- 医院
- Fujian Medical University Union Hospital
- 状态
- 招募中
- 登记库
- NCT07561892
-
研究 Predicting Patient Relapse After Allogeneic Hematopoietic Stem Cell Transplantation: A Comparison of Measurable Residual Disease (MRD) Assessment by Digital Polymerase Chain Reaction and Conventional MRD
- 主要研究者
- Xiao-Jun Huang · Professor
- 医院
- Peking University People's Hospital
- 状态
- 招募中
- 登记库
- NCT06211166
-
研究 A Single-Arm, Multicenter, Open-Label, Dose- Escalating and Expanding,Phase I/II Study of SKLB1028 Combined With "7+3" Standard Chemotherapy in Patients With Newly Diagnosed Acute Myeloid Leukemia (AML)
- 医院
- West China Hospital, Sichuan University
- 状态
- 招募中
- 登记库
- NCT05445154
-
研究 Study on the Efficacy and Safety of VMAC Combined With Donor Lymphocyte Infusion (DLI) in the Treatment of Patients With Relapse of Acute Myeloid Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation
- 医院
- Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College
- 状态
- 招募中
- 登记库
- NCT06447090
-
研究 A Multi-center Prospective Single Arm Clinical Study of Prolonged Ultra Low-dose Decitabine Combined With Venetoclax (Bcl-2 Inhibitor) as First Line Treatment for Elderly Acute Myeloid Leukemia and High-risk Myelodysplastic Syndromes
- 主要研究者
- Weiyan Zheng · Clinical Professor
- 医院
- First Affiliated Hospital of Guangzhou Medical University
- 状态
- 招募中
- 登记库
- NCT06046313
-
研究 Super-universal CD7 CART (supCD7 CART) Cell Injection in the Treatment of Relapsed or Refractory CD7 Positive Hematologic Malignancies: a Prospective, Single-arm, Single-center Clinical Study.
- 医院
- Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College
- 状态
- 招募中
- 登记库
- NCT07153068
-
研究 A Prospective, Open-label, Randomized Controlled, Multicenter Clinical Study of Haploidentical Hematopoietic Stem Cell Transplantation Using a TBI or TMLI Conditioning Regimen for Pediatric Acute Lymphoblastic Leukemia
- 主要研究者
- Xiangbo Wan · Professor
- 医院
- First Affiliated Hospital of Zhengzhou University
- 状态
- 招募中
- 登记库
- NCT06559345
-
研究 The Significance of Serum Ferritin in the Diagnosis, Differential Diagnosis, and Prognosis of Immune-related Adverse Event (irAE)
- 医院
- Tianjin Medical University Cancer Institute & Hospital
- 状态
- 招募中
- 登记库
- NCT06702566
-
研究 Safety and Efficacy of Universal Off-the-shelf CAR-NK Cells Targeted CD123 (JD123 Injection) in the Treatment of Refractory or Relapsed CD123-positive Acute Myeloid Leukemia
- 主要研究者
- Xiao-Jun Huang · Professor
- 医院
- Peking University People's Hospital
- 状态
- 招募中
- 登记库
- NCT06201247
-
研究 Exploratory Clinical Study of JAK1 Inhibitor Golidocitnib in the Treatment of Relapsed/Refractory Indolent T/NK-Cell Lymphomas：An Open, Prospective, Exploratory Clinical Trial
- 医院
- Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College
- 状态
- 招募中
- 登记库
- NCT06716658
-
研究 A Single-Center, Prospective, Single-Arm Phase II Clinical Study of Consolidation With High-Dose Cytarabine Following Deep Molecular Remission Induced by Gilteritinib Plus VA Regimen in Newly Diagnosed Intermediate-Risk Fit AML Patients With FLT3-ITD Mutation
- 主要研究者
- Jie Sun · Principle Attending, Associated Professor
- 医院
- The First Affiliated Hospital, Zhejiang University School of Medicine
- 状态
- 招募中
- 登记库
- NCT07259707
-
研究 A Clinical Study of Inaticabtagene Autoleucel (Inati-cel; CNCT19) Treatment for B-Cell Acute Lymphoblastic Leukemia(B-ALL) Patients in First Complete Remission (CR1)，Minimal Residual Disease(MRD) Positive
- 主要研究者
- Jin Wang · chief physician, MD, PhD
- 医院
- Ruijin Hospital
- 状态
- 招募中
- 登记库
- NCT06718244
-
研究 Donor Derived CD117 CAR-T Cells in the Treatment of Relapsed/Refractory Acute Myeloid Leukemia
- 主要研究者
- He Huang · Principal Investigator
- 医院
- First Affiliated Hospital of Guangzhou Medical University
- 状态
- 招募中
- 登记库
- NCT07144020
-
研究 CD123-Targeted CD16 Antibody-Modified NK Cell Immunotherapy for Refractory/Relapsed Acute Myeloid Leukemia (R/R AML)
- 主要研究者
- Chunji Gao · Principal Investigator
- 医院
- Chinese PLA General Hospital
- 状态
- 招募中
- 登记库
- NCT06835140
-
研究 A Clinical Study to Evaluate the Safety and Efficacy of CLL1 and CD38 Dual-Target CAR-T Cell Injection in the Treatment of Relapsed or Refractory Acute Myeloid Leukemia
- 医院
- Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College
- 状态
- 招募中
- 登记库
- NCT06880354
-
研究 CD19/CD22 Bispecific CAR-T Cell Therapy for Relapsed/Refractory B-cell Lymphoma or Acute Lymphoblastic Leukemia: a Prospective, Single-arm, Single-center, Phase 2 Clinical Trial
- 主要研究者
- LIANG WANG · Director of the department of hematology
- 医院
- Beijing Tongren Hospital
- 状态
- 招募中
- 登记库
- NCT06081478
-
研究 Prospective, Multicenter, Real-world Study of Dolasetron Mesylate Injection for the Prevention of Chemotherapy-induced Nausea and Vomiting in Children With Acute Lymphoblastic Leukemia
- 主要研究者
- Tianping Chen · Associate chief physician
- 医院
- Anhui Provincial Children's Hospital
- 状态
- 招募中
- 登记库
- NCT06756022
-
研究 A Phase II/III Study of ICP-248 in Combination With Orelabrutinib in Patients With Treatment-naïve Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
- 医院
- First Affiliated Hospital of Guangzhou Medical University
- 状态
- 招募中
- 登记库
- NCT06378138
-
研究 Tracjectories and Predictors of Chemotherapy Induced Peripheral Neuropathy in Children With Acute Lymphoblastic Leukemia: A Perspective Longitudinal Study
- 主要研究者
- Dr Eva Ho · Associate professor
- 医院
- Henan Cancer Hospital
- 状态
- 招募中
- 登记库
- NCT07326930
-
研究 A Multicenter, Randomized, Open-Label, Phase III Clinical Study to Evaluate the Efficacy and Safety of HMPL-306 vs. Salvage Chemotherapy Regimens in Patients With IDH1- and IDH2-mutated Relapsed/Refractory Acute Myeloid Leukemia (R/R AML)
- 医院
- First Affiliated Hospital of Guangzhou Medical University
- 状态
- 招募中
- 登记库
- NCT06387069
-
研究 A Multicenter, Prospective, Single-Arm Study of Venetoclax, Chidamide, and Chiglitazar Sodium (VCC) in Patients With Relapsed/Refractory Acute Myeloid Leukemia
- 主要研究者
- Bing, Xu · Dr. Bing Xu
- 医院
- First Affiliated Hospital of Guangzhou Medical University
- 状态
- 招募中
- 登记库
- NCT07783100
-
研究 A Clinical Study to Explore the Safety, Efficacy, and Pharmacokinetics of CT0596 CAR-T Cell Injection in Patients With Relapsed/Refractory Multiple Myeloma and Relapsed/Refractory Plasma Cell Leukemia
- 状态
- 招募中
- 登记库
- NCT06718270
-
研究 Efficacy Study of Blinatumomab Clean Up Early Residual Disease for Newly Diagnosed Pediatric B Lymphoblastic Leukemia
- 主要研究者
- Shuhong Shen · Chair of hematology oncology department of SCMC
- 医院
- Anhui Provincial Children's Hospital
- 状态
- 招募中
- 登记库
- NCT06607419
-
研究 A Clinical Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of B019 Injection in Subjects With Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia.
- 医院
- Peking University People's Hospital
- 状态
- 招募中
- 登记库
- NCT06927466
-
研究 Safety and Efficacy Study of Demethylating Agents With Venetoclax in Preventing Recurrence of High-risk T-cell Lymphoblastic Lymphoma/Leukemia After Transplantation
- 主要研究者
- Xianmin Song, MD · Professor
- 医院
- Shanghai General Hospital
- 状态
- 招募中
- 登记库
- NCT06686108
-
研究 A Phase 3, Open-Label, Randomized Study to Evaluate the Safety and Efficacy of BGB-16673 Compared to Pirtobrutinib in Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
- 医院
- Peking Union Medical College Hospital
- 状态
- 招募中
- 登记库
- NCT06973187
-
研究 A Randomized, Controlled, Double-Blind, Multicenter, Phase Ⅲ Study to Evaluate the Efficacy and Safety of IMM01 (Timdarpacept) in Combination With Azacitidine in Patients With Newly Diagnosed Chronic Myelomonocytic Leukemia (CMML1-2)
- 医院
- Anhui Provincial Hospital
- 状态
- 招募中
- 登记库
- NCT06647862
-
研究 Clinical Study on the Safety and Efficacy of CD19/CD22 CAR-T Cell Therapy in MRD-Positive B-lineage Acute Lymphoblastic Leukemia in Children.
- 医院
- Guangzhou Women and Children's Medical Center
- 状态
- 招募中
- 登记库
- NCT06752785
-
研究 The Safety and Efficacy of RD06-03 CART Cell Injection in Patients With Relapsed or Refractory B-lymphoblastic Leukemia
- 主要研究者
- Xiaoyu Zhu · Chief Prof.
- 医院
- Anhui Provincial Hospital
- 状态
- 招募中
- 登记库
- NCT06307600
-
研究 A Single-center, Single-arm, Prospective Clinical Study of Intermediate-dose Cytarabine in Combination With Venetoclax for Consolidation Therapy of Middle- and High-risk Acute Myeloid Leukemia in The Elderly
- 主要研究者
- Yehui Tan · Professor
- 医院
- The First Hospital of Jilin University
- 状态
- 招募中
- 登记库
- NCT06990321
-
研究 Phase 2 Trial of Menin Inhibitor BN104 as Post Hematopoietic Stem Cell Transplantation Maintenance in Patients With Acute Leukemia
- 主要研究者
- Chen Suning · Prof.
- 医院
- First Affiliated Hospital of Guangzhou Medical University
- 状态
- 招募中
- 登记库
- NCT07101497
-
研究 A Prospective, Randomized Controlled Clinical Study on the Efficacy and Safety of the TmBU Regimen Versus mBUCY Regimen for Conditioning Before Allo-HSCT in High-risk or Relapsed/Refractory Acute Leukemia
- 主要研究者
- Sheng-Li Xue, MD · Prof.
- 医院
- First Affiliated Hospital of Guangzhou Medical University
- 状态
- 招募中
- 登记库
- NCT06816134
-
研究 A Phase I Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of BL-M11D1 in Relapsed/Refractory Acute Myeloid Leukemia (AML) Patients
- 医院
- Anhui Provincial Hospital
- 状态
- 招募中
- 登记库
- NCT05924750
-
研究 Prospective Single-Arm Clinical Study of Thiotepa-Containing Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation in Chronic Myelomonocytic Leukemia
- 主要研究者
- Sun Yuqian · Principal Investigator
- 医院
- Peking University People's Hospital
- 状态
- 招募中
- 登记库
- NCT07588594
-
研究 A Novel Post-transplant Regimen of PT/FLU+CY for Selectively Promoting Unrelated Cord Blood Engraftment in Haploidentical-cord Transplantation in Childhood Leukemia: a Single-arm, Multi-center Trial
- 医院
- Nanfang Hospital
- 状态
- 招募中
- 登记库
- NCT06155188
-
研究 A Phase 3 Open-Label, Randomized Study of Pirtobrutinib (LOXO-305) Versus Ibrutinib in Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (BRUIN-CLL-314)
- 医院
- Second Xiangya Hospital of Central South University
- 状态
- 招募中
- 登记库
- NCT05254743
-
研究 A Single-arm, Dose-escalation and Dose-expansion Phase I Clinical Study to Evaluate the Tolerability, Safety and Preliminary Efficacy of BG1805 Injection in the Treatment of Relapsed or Refractory Acute Myeloid Leukemia
- 医院
- Zhujiang Hospital of Southern Medical University
- 状态
- 招募中
- 登记库
- NCT06118788
-
研究 A Prospective, Multicenter, Randomized Controlled Study on the MA+AZA Regimen for the Treatment of Newly Diagnosed Acute Myeloid Leukemia (AML)
- 医院
- First Affiliated Hospital of Zhengzhou University
- 状态
- 招募中
- 登记库
- NCT06345365
-
研究 A Phase 3 Randomized, Open-Label, Multicenter Study of Sonrotoclax Plus Anti-CD20 Antibody Therapies Versus Venetoclax Plus Rituximab in Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
- 医院
- China-Japan Friendship Hospital
- 状态
- 招募中
- 登记库
- NCT06943872
-
研究 A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Study of Bleximenib, Venetoclax and Azacitidine for the Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia Harboring KMT2A Rearrangements or NPM1 Mutations Who Are Ineligible for Intensive Chemotherapy
- 医院
- Peking University First Hospital
- 状态
- 招募中
- 登记库
- NCT06852222
-
研究 A Clinical Study to Investigate the Safety and Efficacy of Off-the-Shelf iNKT Cell Injection Targeting CD33/CD70 in Adult Patients With Relapsed/Refractory Acute Myeloid Leukemia
- 医院
- Shenzhen People's Hospital
- 状态
- 尚未招募
- 登记库
- NCT07676006
-
研究 Clinical Study on the Safety and Efficacy of QH101 in Patients With Relapsed/Refractory Acute Myeloid Leukemia(R/R AML) and Relapsed/Refractory Myelodysplastic Syndromes(R/R MDS)
- 主要研究者
- Xiaoyu Zhu · Director of Hematology Department
- 医院
- Anhui Provincial Hospital
- 状态
- 尚未招募
- 登记库
- NCT07131085
-
研究 A Multicenter, Prospective Clinical Study of Olverembatinib Combined With Blinatumomab in the Treatment of Adult de Novo Philadelphia Chromosome Positive Acute Lymphoid Leukemia
- 主要研究者
- Chen Suning · Principal Investigator
- 医院
- First Affiliated Hospital of Soochow University
- 状态
- 尚未招募
- 登记库
- NCT05931757
-
研究 Single-Arm, Multicenter, Prospective Phase II Clinical Study of Rituximab Combined With Pirtobrutinib, Lisaftoclax and Liposomal Mitoxantrone for Richter Syndrome Transformed From Chronic Lymphocytic Leukemia
- 医院
- Henan Cancer Hospital
- 状态
- 尚未招募
- 登记库
- NCT07831395
-
研究 Comparing the Efficacy and Safety of Decitabine-Fludarabine-busulfan (Dec-FB4) and Fludarabine-busulfan (FB4) as Conditioning Regimens for AML-MR
- 主要研究者
- Hu Xiaoxia · Principal Investigator
- 医院
- Ruijin Hospital
- 状态
- 尚未招募
- 登记库
- NCT06297772
-
研究 A Prospective, Multicenter, Randomized Controlled, Open Label, Non-Inferiority Study Comparing the Efficacy and Safety of the VA Regimen (Venetoclax Combined With Azacitidine) With the "3+7" Regimen in the Treatment of Newly Diagnosed AML Patients With NPM1 or IDH1/IDH2 Mutations
- 主要研究者
- Shen yang · Chief Physician, Professor, Department of Hematology
- 医院
- Ruijin Hospital
- 状态
- 尚未招募
- 登记库
- NCT07664839
-
研究 A Phase 1b/2 Study of AK117 (Anti-CD47 Antibody) in Combination With Azactidine Plus Venetoclax in Patients With Acute Myeloid Leukemia
- 医院
- Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College
- 状态
- 尚未招募
- 登记库
- NCT06387420
-
研究 A Clinical Study to Investigate the Safety and Efficacy of CT0991 in Patients With Relapsed/Refractory Acute Myeloid Leukemia.
- 主要研究者
- MEI HENG · Principal Investigator
- 医院
- Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
- 状态
- 尚未招募
- 登记库
- NCT07233018
-
研究 Effectiveness and Safety of Inotuzumab Ozogamicin±Donor Lymphocyte Infusion for Relapsed B Cell Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma After Allogeneic Hematopoietic Stem Cell Transplantation：Phrase II, Multicenter Study
- 主要研究者
- Yi Luo · Clinical Professor
- 医院
- First Affiliated Hospital of Guangzhou Medical University
- 状态
- 尚未招募
- 登记库
- NCT06861348
-
研究 A Prospective, Multicenter, Open-label, Randomized Controlled Trial of SHR2554 Plus Azacitidine in Overlapped Sequential Combination With Modified BUCY Conditioning Regimen in Patients With High-risk or Relapsed/Refractory Acute Leukemia and Myelodysplastic Neoplasms Secondary IDs
- 主要研究者
- Limin Liu,MD · Principal Investigator
- 医院
- First Affiliated Hospital of Guangzhou Medical University
- 状态
- 尚未招募
- 登记库
- NCT07575412
-
研究 Safety and Efficacy of CLL1 CAR-T Followed by Allogeneic Hematopoietic Stem Cell Transplantation in the Treatment of Relapsed/Refractory Acute Myeloid Leukemia
- 主要研究者
- Donghua Zhang · professor
- 医院
- Tongji Hospital, Tongji Medical College, Huazhong University of Science & Technology
- 状态
- 尚未招募
- 登记库
- NCT07342244
-
研究 Assessment of the Safety and Efficacy of Hema-NeoTIL01 Cell Infusion Therapy in Relapsed/Refractory Acute Leukemia: A Single-Arm, Open-Label, Prospective Study
- 医院
- First Affiliated Hospital of Guangzhou Medical University
- 状态
- 尚未招募
- 登记库
- NCT06559644
-
研究 An Early Exploratory Clinical Study on the Safety, Tolerability, and Preliminary Efficacy of JY231 Injection in the Treatment of Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia (B-ALL)
- 主要研究者
- He Huang · Professor, Director of the Bone Marrow Transplantation Center
- 医院
- The First Affiliated Hospital, Zhejiang University School of Medicine
- 状态
- 尚未招募
- 登记库
- NCT06902025
-
研究 Phase I Clinical Study of CD19-targeting Chimeric Antigen Receptor T Lymphocyte (MC-1-50) for the Treatment of Relapsed/Refractory CD19-positive B-cell Acute Lymphoblastic Leukemia (B-ALL)
- 医院
- Ruijin Hospital
- 状态
- 尚未招募
- 登记库
- NCT06641024
-
研究 A Multicenter Prospective Study on Structuralized Follow-up Model Construction and Late Effect Burden of Childhood Hematological Malignancy Survivors (HEM-SURVIVE)
- 主要研究者
- zhangjingying · Principal Investigator
- 医院
- Children's Hospital Zhejiang University School of Medicine
- 状态
- 尚未招募
- 登记库
- NCT07483749
-
研究 A Single-Arm, Prospective Clinical Study of the Efficacy and Safety of VABu Conditioning Regimen in Allogeneic Hematopoietic Stem Cell Transplantation for Non-High-Risk AML Patients in CR1 With Low Performance Status (ECOG ≥ 2) or High Hematopoietic Cell Transplantation-Specific Comorbidity Index (HCT-CI ≥ 2)
- 医院
- First Affiliated Hospital of Soochow University
- 状态
- 尚未招募
- 登记库
- NCT07762508
-
研究 An Exploratory Clinical Study Evaluating the Safety and Pharmacokinetic Profile of SNC116 in Adult Patients With Relapsed/Refractory B-cell Acute Lymphoblastic Leukemia
- 医院
- The First Hospital of Jilin University
- 状态
- 尚未招募
- 登记库
- NCT07830238
-
研究 A Multicenter, Open-Label, Phase 1/2 Clinical Study of the Safety and Efficacy of Aclarubicin Combined With Azacitidine and Venetoclax in the Treatment of Acute Myeloid Leukemia
- 主要研究者
- Junmin Li · Chief Physician of hematology
- 医院
- Ruijin Hospital
- 状态
- 尚未招募
- 登记库
- NCT07486726
-
研究 Efficacy and Safety of Maintenance Treatment With Chidamide, Venetoclax, and Azacitidine for Treatment-Naive Acute Myeloid Leukemia Patients Achieving Complete Remission: A Multicenter Study
- 医院
- Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
- 状态
- 尚未招募
- 登记库
- NCT07521124
-
研究 A Multicenter, Open, Single-arm Phase I Dose-escalation and Dose-expansion Clinical Study: Evaluating the Safety, Tolerability, Pharmacokinetic Characteristics, and Preliminary Efficacy of FXS0683 Tablets in Patients With Relapsed or Refractory Hematologic Malignancies.
- 医院
- Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College
- 状态
- 尚未招募
- 登记库
- NCT07616089
-
研究 A Prospective Study on the Efficacy and Safety of Venetoclax, Azacitidine, and Homoharringtonine (VAH) Combination as a Bridging Regimen to Allogeneic Hematopoietic Stem Cell Transplantation in Relapsed/Refractory Acute Myeloid Leukemia
- 医院
- Ruijin Hospital
- 状态
- 尚未招募
- 登记库
- NCT07091006
-
研究 Efficacy and Safety of Zanubrutinib, Obinutuzumab, and Bendamustine (ZGB) Regimen for First-Line Treatment of Chronic Lymphocytic Leukemia: A Single-Arm, Prospective Study
- 主要研究者
- Ou Bai, MD/PHD · Director
- 医院
- The First Hospital of Jilin University
- 状态
- 尚未招募
- 登记库
- NCT07003464
-
研究 A Prospective, Open-Label, Single-Arm, Two-Cohort Phase 2 Clinical Study to Evaluate the Efficacy and Safety of Bcl-2 Inhibitor Combined With Azacitidine in the Treatment of Newly Diagnosed Mixed Phenotype Acute Leukemia
- 主要研究者
- Chen Suning · Doctor
- 医院
- First Affiliated Hospital of Guangzhou Medical University
- 状态
- 尚未招募
- 登记库
- NCT07573670
-
研究 This is a Multicenter, Retrospective Real-world Study of BTK Inhibitor in the Treatment of Chronic Lymphocytic Leukemia in China
- 主要研究者
- Xiao-Jun Huang · Prof.
- 医院
- Peking University People's Hospital
- 状态
- 尚未招募
- 登记库
- NCT06557304
本页仅分享公开登记的研究信息，不推荐也不鼓励参加任何研究。参加完全自愿，且未经批准治疗的风险尚不明确；请直接联系医院了解入组条件与知情同意细节。
拥有国家临床重点专科记录的医院
显示医院记录 21 家拥有重点专科记录的医院
每一行都是在某疾病所归属专科中拥有国家临床重点专科记录的医院。这是对已发布名单的记录，既不构成推荐，也不是排名。
21 家拥有匹配的国家临床重点专科记录的医院。
以中文写出的数值按来源原样引用。
患者报告的情况
仅为汇总数据：一项全国性结果，附其来源与所指年份。这不是患者证言，也不是关于某一个人的陈述。
据 National Health Commission - 2023 national tertiary public hospital performance monitoring circular (国卫医政函〔2025〕55 号)（2023）报道：National inpatient satisfaction / outpatient satisfaction — 95.42 / 93.95 score, 0-100。
National aggregate across the 2,168 tertiary public hospitals that took part in the national performance monitoring (all conditions combined; not disease-specific, not hospital-specific).
来源：National Health Commission - 2023 national tertiary public hospital performance monitoring circular (国卫医政函〔2025〕55 号) — https://www.gov.cn/zhengce/zhengceku/202503/content_7016208.htm — 2023 — A 级
关于该疾病的问题
我们不能提供医疗建议，但可以回答关于本页以及在中国安排就医的问题。
ICD 编码
显示编码表 5 个 ICD 编码
| 版本 | 编码 | 该版本中的名称 |
|---|---|---|
| ICD-10-WHO | C91 | Lymphoid leukaemia |
| ICD-10-WHO | C92 | Myeloid leukaemia |
| ICD-10-WHO | C93 | Monocytic leukaemia |
| ICD-10-WHO | C94 | Other leukaemias of specified cell type |
| ICD-10-WHO | C95 | Leukaemia of unspecified cell type |
各行为该疾病的 WHO ICD-10 条目，按原样引用。
来源与证据
- 来源 URL
- https://www3.ha.org.hk/cancereg/tc/icd10.html
- 来源协议
- https
- 来源类型
- 第三方汇编
- 证据等级
- A ——由卫生健康委员会、国家级研究机构或大学所述
- 获取日期
- 2026-10-01